Marks Group Wealth Management, Inc Abbott Laboratories Transaction History

Marks Group Wealth Management, Inc

$1.02 Billion
Q2 2025

A detailed history of Marks Group Wealth Management, Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Marks Group Wealth Management, Inc holds 7,981 shares of ABT stock, worth $1.01 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

7,981

Previous 8,104 1.52%

Holding current value

$1.01 Million

Previous $1.07 Million 1.02%

% of portfolio

0.11%

Previous 0.11%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 22, 2025	SELL	$123.95 - $138.08 $15,245 - $16,983	-123 Reduced 1.52%	7,981 $1.09 Million
Q1 2025 May 01, 2025	BUY	$111.1 - $140.22 $30,219 - $38,139	272 Added 3.47%	8,104 $1.07 Million
Q3 2024 Oct 30, 2024	SELL	$100.07 - $118.13 $6,404 - $7,560	-64 Reduced 0.81%	7,832 $892,000
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $11,583 - $12,930	-115 Reduced 1.44%	7,896 $820,000
Q1 2024 Apr 29, 2024	SELL	$109.52 - $120.96 $78,525 - $86,728	-717 Reduced 8.21%	8,011 $910,000
Q4 2023 Feb 01, 2024	BUY	$90.19 - $110.4 $3,787 - $4,636	42 Added 0.48%	8,728 $960,000
Q3 2023 Oct 30, 2023	SELL	$95.53 - $114.62 $35,059 - $42,065	-367 Reduced 4.05%	8,686 $841,000
Q2 2023 Jul 19, 2023	SELL	$100.78 - $112.29 $5.69 Million - $6.34 Million	-56,460 Reduced 86.18%	9,053 $986,000
Q1 2023 May 03, 2023	BUY	$96.86 - $114.01 $342,593 - $403,253	3,537 Added 5.71%	65,513 $6.63 Million
Q4 2022 Feb 06, 2023	BUY	$95.06 - $111.52 $65,876 - $77,283	693 Added 1.13%	61,976 $6.81 Million
Q3 2022 Nov 10, 2022	BUY	$96.76 - $112.03 $156,944 - $181,712	1,622 Added 2.72%	61,283 $5.93 Million
Q2 2022 Aug 09, 2022	BUY	$102.07 - $123.37 $367,349 - $444,008	3,599 Added 6.42%	59,661 $6.48 Million
Q1 2022 May 10, 2022	BUY	$114.02 - $139.04 $459,500 - $560,331	4,030 Added 7.75%	56,062 $6.64 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $120,266 - $147,259	-1,041 Reduced 1.96%	52,032 $4.99 Million
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $80,262 - $88,793	688 Added 1.31%	53,073 $6.28 Million
Q2 2021 Aug 10, 2021	BUY	$105.79 - $124.53 $329,535 - $387,910	3,115 Added 6.32%	52,385 $6.08 Million
Q1 2021 May 17, 2021	BUY	$108.84 - $128.23 $58,120 - $68,474	534 Added 1.1%	49,270 $5.91 Million
Q4 2020 Feb 08, 2021	BUY	$105.0 - $114.42 $8,715 - $9,496	83 Added 0.17%	48,736 $5.34 Million
Q3 2020 Nov 10, 2020	BUY	$91.64 - $111.29 $4.09 Million - $4.97 Million	44,638 Added 1111.78%	48,653 $5.3 Million
Q2 2020 Aug 10, 2020	BUY	$76.57 - $98.0 $57,733 - $73,892	754 Added 23.12%	4,015 $367,000
Q4 2019 Feb 12, 2020	BUY	$78.51 - $87.4 $256,021 - $285,011	3,261 New	3,261 $283,000

Others Institutions Holding ABT

# of Institutions

3,572

Shares Held

1.37B

Call Options Held

9.75M

Put Options Held

8.87M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $222B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marks Group Wealth Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Marks Group Wealth Management, Inc with notifications on news.

Account

Marks Group Wealth Management, Inc Abbott Laboratories Transaction History